Position in FTRE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,900,908
+$8,520,804 QoQ
Shares Held
626,489
+148.0% QoQ
Ownership
0.659%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#32
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Derivatives in FTRE
reported options exposure · as of Dec 31, 2025CallValue
$1,740,525
CallShares
100,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. FTRE ranks #103 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in FTRE
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,900,908 | 626,489 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,380,104 | 252,665 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,579,798 | 2,004,626 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $1,740,525 | 100,900 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $11,394,028 | 1,353,210 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,599,285 | 1,740,746 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $26,419,111 | 3,499,220 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $373,000 | 20,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $11,521,205 | 617,759 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $8,112,750 | 435,000 | Put | Sole | 2025-02-14 | |
| 2024-09-30 | $2,324,000 | 116,200 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $654,827 | 28,056 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $6,301,800 | 270,000 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $1,400,400 | 60,000 | Put | Sole | 2024-08-14 | |
| 2024-03-31 | $4,014,000 | 100,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $401,400 | 10,000 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $3,815,093 | 109,315 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,805,920 | 308,007 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||